Amerigen Pharmaceuticals, Inc.
✓ Verified ManufacturerAbout
Amerigen Pharmaceuticals, Inc. is a specialized generic pharmaceutical manufacturer headquartered in Lyndhurst, New Jersey, focused on developing and producing high-quality, affordable medicines for both the United States and Chinese markets. Founded in 2007, this privately-held company operates with a unique dual-market strategy, leveraging western management systems and quality standards to serve two of the world's most important pharmaceutical markets. The company maintains its primary manufacturing facility in Suzhou, China, near Shanghai, which holds both US FDA and Chinese CFDA approvals for finished dose production. This strategic location enables Amerigen to efficiently serve both target markets while maintaining strict regulatory compliance and quality assurance protocols. The Lyndhurst office houses executive management, product development, business development, finance, regulatory affairs, and commercial operations teams. Amerigen specializes in orally delivered generic pharmaceutical products that present unique development challenges, requiring specialized manufacturing technologies, high containment capabilities, and complex regulatory navigation. The company currently maintains an active portfolio of products under development for ANDA filing with the FDA, while already having nine approved products for sale in the Chinese market. With FDA GMP inspection approval and CFDA manufacturing certifications, Amerigen demonstrates its commitment to international quality standards. The company's expertise in navigating complex intellectual property landscapes and regulatory requirements positions it as a capable partner for challenging generic pharmaceutical development and manufacturing projects across both American and Chinese pharmaceutical markets.